BiomEdit LLC was set up last year by Greenfield-based Elanco Animal Health and Boston-based Ginkgo Bioworks to make everything from food to therapeutics for animals. It’s already raised $36.5 million in venture capital for its work.
GeniPhys has developed a material known as Collymer, a highly-purified form of collagen that can be used to replace tissue that is lost in wounds and also forms “stable, fibrillar collagen scaffolds” that can help rebuild lost tissue.
The Advanced Research Projects Agency for Health, or ARPA-H, is looking for cities that can help design biomedical products, enhance clinical trials and bring new health products to market. Winning bidders would land hundreds of jobs.
Patricia Martin, the group’s president and CEO since 2019, last month announced she would step down to examine opportunities in the private sector and urged industry leaders to take a fresh look at the organization.
Steven J. Favaloro brings a background in finance in the life sciences industry to his new positions as president and CEO.
Patty Martin, president and CEO of BioCrossroads since 2019, said she plans to leave the organization to examine opportunities in the private sector.
The move will create at least 100 new jobs at the plant, located in Research Triangle Park, the largest research park in the country.
The IU SciTech corridor will begin at the corner of Michigan and West streets, one of the main entrances to the downtown campus and house both IU and Purdue programs, President Pamela Whitten told the university’s board Friday.
The company plans to occupy about 3,200 square feet of the 30,000-square-foot three-story building north of the ellipse at the Nickel Plate District Amphitheater.
The acquisition is designed to accelerate Indianapolis-based Corteva’s biologicals business and make it one of the largest players in the market.
Corteva Inc., the Indianapolis-based seed and insecticide giant, is cutting 5% of its global workforce, or roughly 1,000 workers, as it reduces its portfolio of products and streamlines its operations.
It was supposed to be a “good-news” day for Indianapolis-based biotech Point Biopharma Global Inc. Instead, the company saw its stock get battered Monday, losing as much as 38% of its value, after it released a pair of announcements.
RayzeBio Inc., a private company founded in 2020 in San Diego, said it will invest in improvements and equipment in a former warehouse for e-commerce giant Amazon.com Inc.
City officials said Stevanato Group wants to increase its total investment in its Fishers plant to $512 million and its hiring plan to 515 employees. The facility is under construction near 126th Street and Cumberland Road.
BiomEdit, one of Indiana’s newest life-science companies, said Monday it will locate its headquarters in Fishers, but hinted it could eventually move to the new $100 million Elanco Animal Health headquarters campus now under construction in Indianapolis.
A panel of Indiana life science experts on Friday said the state could become more competitive for large investments and jobs if it doubled down on the kind of collaborations and partnerships that other states have used to their advantage.
The expansion comes on top of more than 1,000 positions the drugmaker has added since Jan. 1, 2021, bringing its current Bloomington workforce total to more than 4,000, which includes employees and workers provided by staffing agencies.
Prevounce Health, which launched in 2019 in Los Angeles, relocated its operations to Indianapolis last fall and just landed $4.5 million in investment funding which the company says will help it expand and double its workforce in coming months.
The university announced the gift Thursday morning from Jeff Albers, who graduated from the Kelley School in 1993, and his wife, Alison. Albers has spent more than 25 years in the biopharmaceutical industry.
Elanco Animal Health Inc. on Tuesday broke ground and shared new designs for its planned $100 million-plus global headquarters at the former General Motors Stamping Plant site just west of downtown Indianapolis.
